{
  "url": "https://openlegislation.uk/eu-regulation-2011-1160/annex-II",
  "json_url": "https://openlegislation.uk/eu-regulation-2011-1160/annex-II.json",
  "legislation": "eur/2011/1160",
  "legislation_title": "Commission Regulation (EU) No 1160/2011 of 14 November 2011 on the authorisation and refusal of authorisation of certain health claims made on foods and referring to the reduction of disease risk (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2011-1160",
  "path": "annex/II",
  "kind": "annex",
  "number": "II",
  "heading": null,
  "text": "REJECTED HEALTH CLAIMS\nApplication — Relevant provisions of Regulation (EC) No 1924/2006\nNutrient, substance, food or food category\nClaim\nEFSA opinion reference\nArticle 14(1)(a) health claim referring to a reduction of a disease risk\nSoy protein\nSoy protein has been shown to lower/reduce blood cholesterol; blood cholesterol lowering may reduce the risk of (coronary) heart disease\nQ-2009-00672\nArticle 14(1)(a) health claim referring to a reduction of a disease risk\nActimel® Lactobacillus casei DN-114 001 plus yoghurt symbiosis\nFermented milk containing the probiotic Lactobacillus casei DN-114 001 and yoghurt symbiosis decreases presence of Clostridium difficile toxins in the gut (of susceptible ageing people). Presence of Clostridium difficile toxins is associated with the incidence of acute diarrhoea.\nQ-2009-00776",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2011/1160/annex/II",
    "retrieved_at": "2026-11-01T14:49:47.882162+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}